These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21430785)

  • 1. Safety of a non-viral plasmid-encoding dual isoforms of hepatocyte growth factor in critical limb ischemia patients: a phase I study.
    Henry TD; Hirsch AT; Goldman J; Wang YL; Lips DL; McMillan WD; Duval S; Biggs TA; Keo HH
    Gene Ther; 2011 Aug; 18(8):788-94. PubMed ID: 21430785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase I clinical study of naked DNA expressing two isoforms of hepatocyte growth factor to treat patients with critical limb ischemia.
    Gu Y; Zhang J; Guo L; Cui S; Li X; Ding D; Kim JM; Ho SH; Hahn W; Kim S
    J Gene Med; 2011 Nov; 13(11):602-10. PubMed ID: 22015632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia.
    Powell RJ; Simons M; Mendelsohn FO; Daniel G; Henry TD; Koga M; Morishita R; Annex BH
    Circulation; 2008 Jul; 118(1):58-65. PubMed ID: 18559703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Safety and Preliminary Efficacy of Plasmid pUDK-HGF Expressing Human Hepatocyte Growth Factor (HGF) in Patients with Critical Limb Ischemia.
    Cui S; Guo L; Li X; Gu Y; Fu J; Dong L; Song H; Chen X; Lu Y; Hu C; Xiao F; Zhu D; Wu Z; Zhang Q
    Eur J Vasc Endovasc Surg; 2015 Oct; 50(4):494-501. PubMed ID: 26122834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I/IIa clinical trial of therapeutic angiogenesis using hepatocyte growth factor gene transfer to treat critical limb ischemia.
    Morishita R; Makino H; Aoki M; Hashiya N; Yamasaki K; Azuma J; Taniyama Y; Sawa Y; Kaneda Y; Ogihara T
    Arterioscler Thromb Vasc Biol; 2011 Mar; 31(3):713-20. PubMed ID: 21183732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, double-blind, placebo-controlled clinical trial of hepatocyte growth factor plasmid for critical limb ischemia.
    Shigematsu H; Yasuda K; Iwai T; Sasajima T; Ishimaru S; Ohashi Y; Yamaguchi T; Ogihara T; Morishita R
    Gene Ther; 2010 Sep; 17(9):1152-61. PubMed ID: 20393508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease.
    Taniyama Y; Morishita R; Aoki M; Nakagami H; Yamamoto K; Yamazaki K; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
    Gene Ther; 2001 Feb; 8(3):181-9. PubMed ID: 11313789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of patient specific intramuscular injection of HGF plasmid gene therapy on limb perfusion and wound healing in patients with ischemic lower extremity ulceration: results of the HGF-0205 trial.
    Powell RJ; Goodney P; Mendelsohn FO; Moen EK; Annex BH;
    J Vasc Surg; 2010 Dec; 52(6):1525-30. PubMed ID: 21146749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte growth factor as potential cardiovascular therapy.
    Nakagami H; Kaneda Y; Ogihara T; Morishita R
    Expert Rev Cardiovasc Ther; 2005 May; 3(3):513-9. PubMed ID: 15889978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Hepatocyte Growth Factor in the Treatment of Critical Limb Ischemia.
    Gu Y; Cui S; Wang Q; Liu C; Jin B; Guo W; Liu C; Chu T; Shu C; Zhang F; Han C; Liu Y
    Mol Ther; 2019 Dec; 27(12):2158-2165. PubMed ID: 31805256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfection of human HGF plasmid DNA improves limb salvage in Buerger's disease patients with critical limb ischemia.
    Shigematsu H; Yasuda K; Sasajima T; Takano T; Miyata T; Ohta T; Tanemoto K; Obitsu Y; Iwai T; Ozaki S; Ogihara T; Morishita R;
    Int Angiol; 2011 Apr; 30(2):140-9. PubMed ID: 21427651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naked DNA expressing two isoforms of hepatocyte growth factor induces collateral artery augmentation in a rabbit model of limb ischemia.
    Pyun WB; Hahn W; Kim DS; Yoo WS; Lee SD; Won JH; Rho BS; Park ZY; Kim JM; Kim S
    Gene Ther; 2010 Dec; 17(12):1442-52. PubMed ID: 20668482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with critical limb ischemia.
    Kibbe MR; Hirsch AT; Mendelsohn FO; Davies MG; Pham H; Saucedo J; Marston W; Pyun WB; Min SK; Peterson BG; Comerota A; Choi D; Ballard J; Bartow RA; Losordo DW; Sherman W; Driver V; Perin EC
    Gene Ther; 2016 Mar; 23(3):306-12. PubMed ID: 26649448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase 1/2 open-label dose-escalation study of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with painful diabetic peripheral neuropathy.
    Ajroud-Driss S; Christiansen M; Allen JA; Kessler JA
    Mol Ther; 2013 Jun; 21(6):1279-86. PubMed ID: 23609019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease.
    Morishita R; Aoki M; Hashiya N; Makino H; Yamasaki K; Azuma J; Sawa Y; Matsuda H; Kaneda Y; Ogihara T
    Hypertension; 2004 Aug; 44(2):203-9. PubMed ID: 15238569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human hepatocyte growth factor (VM202) gene therapy via transendocardial injection in a pig model of chronic myocardial ischemia.
    Perin EC; Silva GV; Vela DC; Zheng Y; Baimbridge F; Gahremanpour A; Quan X; Hahn W; Kim J; Wood K; Kitamura M
    J Card Fail; 2011 Jul; 17(7):601-11. PubMed ID: 21703533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined Analysis of Clinical Data on HGF Gene Therapy to Treat Critical Limb Ischemia in Japan.
    Morishita R; Shimamura M; Takeya Y; Nakagami H; Chujo M; Ishihama T; Yamada E; Rakugi H
    Curr Gene Ther; 2020; 20(1):25-35. PubMed ID: 32416690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy for diabetic peripheral neuropathy: A randomized, placebo-controlled phase III study of VM202, a plasmid DNA encoding human hepatocyte growth factor.
    Kessler JA; Shaibani A; Sang CN; Christiansen M; Kudrow D; Vinik A; Shin N;
    Clin Transl Sci; 2021 May; 14(3):1176-1184. PubMed ID: 33465273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intramuscular transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb ischemia: a phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial.
    Kawamoto A; Katayama M; Handa N; Kinoshita M; Takano H; Horii M; Sadamoto K; Yokoyama A; Yamanaka T; Onodera R; Kuroda A; Baba R; Kaneko Y; Tsukie T; Kurimoto Y; Okada Y; Kihara Y; Morioka S; Fukushima M; Asahara T
    Stem Cells; 2009 Nov; 27(11):2857-64. PubMed ID: 19711453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No influence of tumor growth by intramuscular injection of hepatocyte growth factor plasmid DNA: safety evaluation of therapeutic angiogenesis gene therapy in mice.
    Matsuki A; Yamamoto S; Nakagami H; Aoki M; Tamai K; Matsumoto K; Nakamura T; Ogihara T; Kaneda Y; Morishita R
    Biochem Biophys Res Commun; 2004 Feb; 315(1):59-65. PubMed ID: 15013425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.